PT1014951E - Composicao de revestimento farmaceutica e metodo para a sua utilizacao - Google Patents
Composicao de revestimento farmaceutica e metodo para a sua utilizacaoInfo
- Publication number
- PT1014951E PT1014951E PT98944756T PT98944756T PT1014951E PT 1014951 E PT1014951 E PT 1014951E PT 98944756 T PT98944756 T PT 98944756T PT 98944756 T PT98944756 T PT 98944756T PT 1014951 E PT1014951 E PT 1014951E
- Authority
- PT
- Portugal
- Prior art keywords
- coating composition
- pharmaceutical coating
- surfactant
- polymer
- composition
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 239000008200 pharmaceutical coating composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5826497P | 1997-09-09 | 1997-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1014951E true PT1014951E (pt) | 2005-03-31 |
Family
ID=22015721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98944756T PT1014951E (pt) | 1997-09-09 | 1998-09-04 | Composicao de revestimento farmaceutica e metodo para a sua utilizacao |
Country Status (10)
Country | Link |
---|---|
US (1) | US7087243B2 (pt) |
EP (1) | EP1014951B1 (pt) |
JP (1) | JP2001515855A (pt) |
AT (1) | ATE282407T1 (pt) |
AU (1) | AU9221898A (pt) |
DE (1) | DE69827650T2 (pt) |
ES (1) | ES2232021T3 (pt) |
HK (1) | HK1029277A1 (pt) |
PT (1) | PT1014951E (pt) |
WO (1) | WO1999012526A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
CA2533150C (en) * | 2003-07-25 | 2013-03-12 | Warner Chilcott Company, Inc. | A doxycycline metal complex in a solid dosage form |
US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
US8080062B2 (en) * | 2008-12-02 | 2011-12-20 | Warsaw Orthopedic, Inc. | Intervertebral implant with fixation mechanism |
US8814912B2 (en) | 2012-07-27 | 2014-08-26 | Zimmer Spine, Inc. | Bone stabilization member with bone screw retention mechanism |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2799241A (en) * | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
US3919436A (en) * | 1971-09-27 | 1975-11-11 | Eisai Co Ltd | Process for preparation of coated medicines |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
JPS5157813A (en) * | 1974-11-14 | 1976-05-20 | Sankyo Co | Ll dooba mataha sonojudotaiseizaino seiho |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4117182A (en) * | 1976-12-23 | 1978-09-26 | Commercial Decal, Inc. | Heat release layer for decalcomanias |
US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
US4217725A (en) * | 1978-10-16 | 1980-08-19 | Mattel, Inc. | Combination doll and accessory articles |
US4200098A (en) | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4329451A (en) | 1980-11-03 | 1982-05-11 | The Dow Chemical Company | Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
JPS5867616A (ja) * | 1981-10-15 | 1983-04-22 | Tanabe Seiyaku Co Ltd | 腸溶性マイクロカプセル |
US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
US4948593A (en) * | 1989-05-15 | 1990-08-14 | Alza Corporation | Osmotic dosage form comprising an estrogen and a progestogen |
US5126146A (en) * | 1989-10-23 | 1992-06-30 | Merck & Co., Inc. | Cellulosic coating |
EP0459516A1 (en) * | 1990-06-01 | 1991-12-04 | Kirin-Amgen, Inc. | Oral dosage form of biologically active proteins |
GB2258810B (en) * | 1991-08-12 | 1996-01-31 | Euro Celtique Sa | Pharmaceutical combination formulation of diltiazem and hydrochlorothiazide |
KR100221695B1 (ko) * | 1991-08-12 | 1999-09-15 | 그린 마틴, 브라이언 쥐 테슬리 | 약학적 구상 제형 |
GB2258613B (en) * | 1991-08-12 | 1996-01-10 | Euro Celtique Sa | Pharmaceutical diltiazem formulation |
ES2149250T3 (es) | 1993-04-23 | 2000-11-01 | Novartis Ag | Dispositivo para la administracion de medicamentos con liberacion controlada. |
WO1995001155A1 (en) * | 1993-07-01 | 1995-01-12 | Unilever N.V. | Oral compositions |
KR100210509B1 (ko) * | 1996-01-10 | 1999-07-15 | 성재갑 | 지속성 동물 성장 호르몬 제형 및 이의 제조 방법 |
-
1998
- 1998-09-04 ES ES98944756T patent/ES2232021T3/es not_active Expired - Lifetime
- 1998-09-04 WO PCT/US1998/018512 patent/WO1999012526A1/en active IP Right Grant
- 1998-09-04 PT PT98944756T patent/PT1014951E/pt unknown
- 1998-09-04 AU AU92218/98A patent/AU9221898A/en not_active Abandoned
- 1998-09-04 JP JP2000510425A patent/JP2001515855A/ja active Pending
- 1998-09-04 AT AT98944756T patent/ATE282407T1/de not_active IP Right Cessation
- 1998-09-04 EP EP98944756A patent/EP1014951B1/en not_active Expired - Lifetime
- 1998-09-04 DE DE69827650T patent/DE69827650T2/de not_active Expired - Lifetime
-
2000
- 2000-12-29 HK HK00108572A patent/HK1029277A1/xx not_active IP Right Cessation
-
2004
- 2004-07-23 US US10/897,669 patent/US7087243B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2001515855A (ja) | 2001-09-25 |
US20050003006A1 (en) | 2005-01-06 |
DE69827650T2 (de) | 2005-11-03 |
ATE282407T1 (de) | 2004-12-15 |
US7087243B2 (en) | 2006-08-08 |
EP1014951B1 (en) | 2004-11-17 |
WO1999012526A1 (en) | 1999-03-18 |
AU9221898A (en) | 1999-03-29 |
ES2232021T3 (es) | 2005-05-16 |
DE69827650D1 (de) | 2004-12-23 |
HK1029277A1 (en) | 2001-03-30 |
EP1014951A1 (en) | 2000-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9607862A (pt) | Composição farmacêutica filmogênica para administração transdérmica | |
BR9406363A (pt) | Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico | |
TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
RS50485B (sr) | Terapeutske kombinacije koje sadrže amplodipin i atorvastatin | |
EE9700194A (et) | Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID | |
DE69525148D1 (de) | Pharmazeutische formulierung | |
PT861666E (pt) | Composicao farmaceutica para utilizacao no tratamento da diabetes | |
DE69801045D1 (de) | Pharmazeutische zusammensetzung zur oralen verabreichung von einem n-piperidin-3-pyrazolcarboxamid-derivat, dessen salzen und deren solvaten | |
ITRM940621A0 (it) | "composizione farmaceutica stabilizzata, relativo solvente e procedimento di preparazione" | |
BR9611367A (pt) | Formulação farmacêutic liofilizada estável | |
BR9607851B1 (pt) | combinaÇço e formulaÇço farmacÊutica. | |
EE9700195A (et) | Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja prokineetilist ainet | |
ATE292453T1 (de) | Antivirale arznei | |
AR012376A1 (es) | Formulacion de gel para la aplicacion topica | |
BR9602915A (pt) | Medicamentos uso e formulação farmacêutica | |
DK1112060T3 (da) | Doseringsform anvendende flydende formulering | |
BR9506106A (pt) | Composto processo para sua preparação medicamento e composição farmacêutica | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
PT101444A (pt) | Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao | |
LV12250A (lv) | Farmaceitiskas kompozicijas uz diklofenaka bazes | |
PT1014951E (pt) | Composicao de revestimento farmaceutica e metodo para a sua utilizacao | |
AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
HRP20000781B1 (en) | Effervescent preparations | |
SE0001916D0 (sv) | Novel formulation |